EUVIMEDEUVIMED entdecken
Crossref

Cimetidine for Pediatric Use in Japan: Rising Prescriptions for a New Indication

Karin Oshima, Eisuke Inage, Shun Toriumi, Kenji Oishi, Hiromichi Yamada, Yosuke Baba, Takahiro Kudo, Yoshikazu Ohtsuka, Ryuta Nishikomori, Hidefumi Nakamura, Nobuaki Michihata, Hiromichi Shoji

The Tohoku Journal of Experimental Medicine · 2026 · 268 (1) · 3-8

DOI: 10.1620/tjem.2025.j075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Tohoku Journal of Experimental Medicine, 2026. Verfasst von Karin Oshima und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Juntendo University, Faculty of Medicine. Hauptthemen laut MEDLINE: Cimetidine, Drug Prescriptions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cimetidine is effective for treating periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome, primarily in children, and is covered by public insurance in Japan. However, as demand for gastric ulcer treatment declines, cimetidine production has been restricted, raising concerns about supply for pediatric patients. We analyzed Japanese prescription trends in adults and children using publicly available data. Specifically, national reimbursement data were used to assess annual cimetidine prescription volumes by age group and pediatric share. Chronological changes were examined based on original formulation supply. In the database, 11 and 6 cimetidine products (including discontinued stock) were available for outpatient and in-hospital dispensing, respectively. Annually, 1.01 million and 80,000 cimetidine tablets (200-mg equivalents) were dispensed for patients under 15 years in outpatient and in-hospital settings, respectively. No inpatient prescriptions were recorded. Pediatric prescriptions peaked at ages 5-9 years, differing from adult trends, and accounted for 2.5% of total prescriptions. Although overall dispensing volumes are declining, pediatric prescriptions are increasing. Despite overall demand decreasing, approximately 1 million 200-mg cimetidine tablets are needed annually for use in children, and pediatric demand is increasing. Therefore, securing production of this new indication is essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CimetidineDrug PrescriptionsHumansChildJapanChild, PreschoolAdolescentAdultInfantFemaleMale

Stichwörter der Autor:innen

autoinflammatory disorderscimetidineinsurance claimpediatricsperiodic fever syndrome

Substanzen

Cimetidine

Autor:innen und Institutionen

  • Department of Pediatrics, Juntendo University, Faculty of Medicine.
  • Department of Pediatrics and Child Health, Kurume University School of Medicine.
  • Department of Development Strategy, National Center for Child Health and Development.
  • Cancer Prevention Center, Chiba Cancer Center Research Institute.

Zitieren

APA

Oshima, K., Inage, E., Toriumi, S., Oishi, K., Yamada, H., Baba, Y., Kudo, T., Ohtsuka, Y., Nishikomori, R., Nakamura, H., Michihata, N., & Shoji, H. (2026). Cimetidine for Pediatric Use in Japan: Rising Prescriptions for a New Indication. The Tohoku Journal of Experimental Medicine, 268(1), 3-8. https://doi.org/10.1620/tjem.2025.j075

Vancouver

Oshima K, Inage E, Toriumi S, Oishi K, Yamada H, Baba Y, et al. Cimetidine for Pediatric Use in Japan: Rising Prescriptions for a New Indication. The Tohoku Journal of Experimental Medicine. 2026;268(1):3-8. doi:10.1620/tjem.2025.j075

BibTeX
@article{Oshima2026,
  author = {Oshima, Karin and Inage, Eisuke and Toriumi, Shun and Oishi, Kenji and Yamada, Hiromichi and Baba, Yosuke and Kudo, Takahiro and Ohtsuka, Yoshikazu and Nishikomori, Ryuta and Nakamura, Hidefumi and Michihata, Nobuaki and Shoji, Hiromichi},
  title = {Cimetidine for Pediatric Use in Japan: Rising Prescriptions for a New Indication},
  journal = {The Tohoku Journal of Experimental Medicine},
  year = {2026},
  volume = {268},
  number = {1},
  pages = {3--8},
  doi = {10.1620/tjem.2025.j075}
}
Kostenlos starten →